Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: January 7, 2026
Indenopyridine Derivatives

l-CDB-4022, RTI-4587-073(l)

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): BIOQUAL, National University of La Plata, Argentina
Inactive
Last updated: January 7, 2026
FibroPlant LNG IUS

Frameless LNG IUS

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): Contrel Research, Belgium, APCOR R&M, Belgium
Inactive
Last updated: January 7, 2026
Femilis LNG IUS
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): Contrel Research, Belgium, APCOR R&M, Belgium
Inactive
Last updated: January 7, 2026
Dihydropyridine Calcium Channel Antagonists

Nifedipine, Amlodipine

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Rawalpindi Medical University, University of Basra, Babcock University
Inactive
Last updated: January 5, 2026
Chongqing Uterine-Shaped IUD

Copper-Plated Uterine Cavity-Shaped IUD (UCDcu), UCu300 IUD

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Single-Country Approval
  • Developer(s)/Researcher(s): Chongqing Medical Equipment Factory Co., Ltd.
Inactive
Last updated: November 21, 2025
Zavesca

Miglustat, N-Butyldeoxynojirimycin (NB-DNJ)

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Permanent
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): University of Washington, Oxford GlycoSciences
Inactive
Last updated: November 21, 2025
T-Cu 320 Hybrid IUD
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Contrel Research, Belgium
Inactive
Last updated: November 21, 2025
Silicone Vas Deferens Occlusive Plugs

Shepard Medical Intra Vas Device (IVD), SHUG

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Permanent
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): Shepherd Medical Company
Inactive
Last updated: November 20, 2025
Phenoxybenzamine Derivatives

"Clean Sheets" Pill

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Undetermined
  • Intended Duration: Short-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): King's College, London, CONRAD
Inactive
Last updated: November 20, 2025
Oviduct Plug
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Fallopian Tube
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Shandong Provincial Family Planning Institute of Science and Technology